{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:50:30Z","timestamp":1791895830897,"version":"4.3.4"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH57440"],"award-info":[{"award-number":["MH57440"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.schres.2026.09.015","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:21:44Z","timestamp":1789813304000},"page":"535-541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hippocampal mechanisms and neural circuitry of negative symptoms in schizophrenia"],"prefix":"10.1016","volume":"297","author":[{"given":"Daniela L.","family":"Uliana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A.","family":"Grace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2026.09.015_bb0005","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1186\/s12888-025-07199-z","article-title":"Pomgulated methionil (LY2140023) in schizophrenia patients: a systematic review and meta-analysis","volume":"25","author":"Aboushawareb","year":"2025","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/758212","article-title":"Pomaglumetad Methionil (LY2140023 monohydrate) and aripiprazole in patients with schizophrenia: a phase 3, multicenter, double-blind comparison","volume":"2014","author":"Adams","year":"2014","journal-title":"Schizophr. Res. Treat."},{"key":"10.1016\/j.schres.2026.09.015_bb0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.2010.05445.x","article-title":"What does the amygdala contribute to social cognition?","volume":"1191","author":"Adolphs","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.schres.2026.09.015_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2010.07.007","article-title":"Updated meta-analyses reveal thalamus volume reduction in patients with first-episode and chronic schizophrenia","volume":"123","author":"Adriano","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.09.015_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2005.11.005","article-title":"Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia?","author":"Aleman","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.schres.2026.09.015_bb0030","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyae061","article-title":"Therapeutic effect of evenamide, a glutamate inhibitor, in patients with treatment-resistant schizophrenia (TRS): final, 1-year results from a phase 2, open-label, rater-blinded, randomized, international clinical trial","volume":"28","author":"Anand","year":"2024","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2026.09.015_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2024.110275","volume":"266","author":"Anand","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.schres.2026.09.015_bb0040","doi-asserted-by":"crossref","DOI":"10.1177\/20451253251414529","article-title":"Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychotics: recent clinical findings from randomized trials","volume":"16","author":"Anand","year":"2026","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.schres.2026.09.015_bb0045","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/schbul\/sbt165","article-title":"Amygdala connectivity differs among chronic, early course, and individuals at risk for developing schizophrenia","volume":"40","author":"Anticevic","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.09.015_bb0050","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/schbul\/sbq068","article-title":"Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions","volume":"36","author":"Barch","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.09.015_bb0055","first-page":"968","article-title":"Role of the prefrontal cortex in altered hippocampal-accumbens synaptic plasticity in a developmental animal model of schizophrenia","volume":"24","author":"Belujon","year":"2014","journal-title":"Cerebral cortex (New York, N.Y.\u202f: 1991)"},{"key":"10.1016\/j.schres.2026.09.015_bb0060","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","article-title":"N-acetyl cysteine as a glutathione precursor for schizophrenia\u2014a double-blind, randomized, placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0065","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/ijnp\/pyy011","article-title":"Human striatal response to reward anticipation linked to hippocampal glutamate levels","volume":"21","author":"Bossong","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2026.09.015_bb0070","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jpsychires.2020.10.047","article-title":"Aberrant striatal coupling with default mode and central executive network relates to self-reported avolition and anhedonia in schizophrenia","volume":"145","author":"Brakowski","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2026.09.015_bb0075","doi-asserted-by":"crossref","first-page":"9130","DOI":"10.1073\/pnas.1300454110","article-title":"Perineuronal nets protect fast-spiking interneurons against oxidative stress","volume":"110","author":"Cabungcal","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.schres.2026.09.015_bb0080","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1037\/abn0000137","article-title":"Frontal-striatum dysfunction during reward processing: relationships to amotivation in schizophrenia","volume":"125","author":"Chung","year":"2016","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.schres.2026.09.015_bb0085","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/schbul\/sbx093","article-title":"N-acetylcysteine in a double-blind randomized placebo-controlled trial: toward biomarker-guided treatment in early psychosis","volume":"44","author":"Conus","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.09.015_bb0090","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2147\/NDT.S225643","article-title":"Negative symptoms in schizophrenia: a review and clinical guide for recognition, assessment, and treatment","volume":"16","author":"Correll","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2026.09.015_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-026-03543-1","article-title":"Interventions for negative symptoms in schizophrenia: efficacy and clinical interpretability in a meta-analysis of 451 randomized controlled trials","author":"Damiani","year":"2026","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.schres.2024.09.030","article-title":"Antipsychotic dopamine D2 affinity and negative symptoms in remitted first episode psychosis patients","volume":"274","author":"De Beer","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.09.015_bb0105","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neubiorev.2020.09.033","article-title":"The thalamic midline nucleus reuniens: potential relevance for schizophrenia and epilepsy","volume":"119","author":"Dolleman-van der Weel","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2026.09.015_bb0110","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1038\/s41467-019-10800-1","article-title":"Modulation of extrasynaptic GABAA alpha 5 receptors in the ventral hippocampus normalizes physiological and behavioral deficits in a circuit specific manner","volume":"10","author":"Donegan","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.schres.2026.09.015_bb0115","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1038\/npp.2016.42","article-title":"Amygdala hyperactivity in MAM model of schizophrenia is normalized by peripubertal diazepam administration","volume":"41","author":"Du","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2026.09.015_bb0120","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/med.22042","article-title":"Beyond dopamine: novel strategies for schizophrenia treatment","volume":"44","author":"Dudzik","year":"2024","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.schres.2026.09.015_bb0125","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1176\/appi.ajp.2019.19030247","article-title":"Limbic hyperactivity in response to emotionally neutral stimuli in schizophrenia: a neuroimaging Meta-analysis of the hypervigilant mind","volume":"176","author":"Dugr\u00e9","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41537-025-00655-5","article-title":"Left amygdala alterations mediate the effects of negative symptoms on social dysfunction in schizophrenia","volume":"11","author":"Fang","year":"2025","journal-title":"Schizophrenia"},{"key":"10.1016\/j.schres.2026.09.015_bb0135","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.eurpsy.2014.01.007","article-title":"Impact of primary negative symptoms on functional outcomes in schizophrenia","volume":"29","author":"Fervaha","year":"2014","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cne.903590111","article-title":"GABAA -receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits","volume":"359","author":"Fritschy","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.schres.2026.09.015_bb0145","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1192\/bjp.2023.63","article-title":"The pathophysiology of negative symptoms of schizophrenia: main hypotheses and open challenges","volume":"223","author":"Galderisi","year":"2023","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0150","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S2215-0366(18)30050-6","article-title":"Negative symptoms of schizophrenia: new developments and unanswered research questions","volume":"5","author":"Galderisi","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpsychires.2021.03.041","article-title":"Reduced resting state functional connectivity in the hippocampus-midbrain-striatum network of schizophrenia patients","volume":"138","author":"Gangadin","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2026.09.015_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2011.10.005","article-title":"Altered age-related trajectories of amygdala-prefrontal circuitry in adolescents at clinical high risk for psychosis: a preliminary study","volume":"134","author":"Gee","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.09.015_bb0165","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.2174\/1381612819666131216114612","article-title":"The role of \u03b15 GABAA receptor agonists in the treatment of cognitive deficits in schizophrenia","volume":"20","author":"Gill","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.schres.2026.09.015_bb0170","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1017\/S146114571400056X","article-title":"Corresponding decrease in neuronal markers signals progressive parvalbumin neuron loss in MAM schizophrenia model","volume":"17","author":"Gill","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2026.09.015_bb0175","article-title":"Gender differences in clinical and psychosocial features among persons with schizophrenia: a mini review","volume":"12","author":"Giordano","year":"2021","journal-title":"Front. Psych."},{"key":"10.1016\/j.schres.2026.09.015_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094467","article-title":"Beyond dopamine receptor antagonism: new targets for schizophrenia treatment and prevention","volume":"22","author":"Gomes","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.schres.2026.09.015_bb0185","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neubiorev.2016.05.030","article-title":"Adolescence as a period of vulnerability and intervention in schizophrenia: insights from the MAM model","volume":"70","author":"Gomes","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2026.09.015_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-026-03513-7","article-title":"The ventral\/anterior hippocampus as a central hub for stress-related dopaminergic circuit dysfunction in psychiatric disorders","author":"Grace","year":"2026","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2026.06.010","article-title":"Antipsychotic drug action, novel treatment targets, and the failure of current clinical trial designs in evaluating new target molecules","author":"Grace","year":"2026","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0200","article-title":"Neuroanatomical and symptomatic sex differences in individuals at clinical high risk for psychosis","volume":"8","author":"Guma","year":"2017","journal-title":"Front. Psychol."},{"key":"10.1016\/j.schres.2026.09.015_bb0205","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/schbul\/sbaa084","article-title":"Deconstructing negative symptoms in individuals at clinical high-risk for psychosis: evidence for volitional and diminished emotionality subgroups that predict clinical presentation and functional outcome","volume":"47","author":"Gupta","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.09.015_bb0210","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jpsychires.2026.07.002","article-title":"Parvalbumin and anxiety across development in female offspring of the MAM neurodevelopmental model of schizophrenia","volume":"201","author":"Gurgel","year":"2026","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2026.09.015_bb0215","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2014.09.041","article-title":"GABAergic mechanisms of hippocampal hyperactivity in schizophrenia","volume":"167","author":"Heckers","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.09.015_bb0220","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00429-007-0150-4","article-title":"Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat","volume":"212","author":"Hoover","year":"2007","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.schres.2026.09.015_bb0225","doi-asserted-by":"crossref","DOI":"10.1126\/science.1255263","article-title":"Fast-spiking, parvalbumin+ GABAergic interneurons: from cellular design to microcircuit function","volume":"345","author":"Hu","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.schres.2026.09.015_bb0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1176\/appi.ajp.160.1.13","article-title":"Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia","volume":"160","author":"Kapur","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0235","doi-asserted-by":"crossref","DOI":"10.1176\/appi.ajp.20241186","article-title":"Long-term safety and efficacy of xanomeline and trospium chloride in schizophrenia: a 52-week open-label extension trial","author":"Kaul","year":"2026","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0240","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2016.05.003","article-title":"Secondary negative symptoms \u2014 a review of mechanisms, assessment and treatment","volume":"186","author":"Kirschner","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.09.015_bb0245","article-title":"Neural activation during cognitive effort-based decision making: associations with avolition in veterans with schizophrenia and bipolar disorder","author":"Leathem","year":"2026","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.schres.2026.09.015_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-025-00667-6","article-title":"Schizophrenia","volume":"11","author":"Leucht","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.schres.2026.09.015_bb0255","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tins.2011.10.004","article-title":"Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia","volume":"35","author":"Lewis","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.schres.2026.09.015_bb0260","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pnpbp.2015.02.012","article-title":"Perspectives on the mGluR2\/3 agonists as a therapeutic target for schizophrenia: still promising or a dead end?","volume":"60","author":"Li","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0265","first-page":"37","article-title":"Why sex differences in schizophrenia?","volume":"1","author":"Li","year":"2016","journal-title":"J. Transl. Neurosci."},{"key":"10.1016\/j.schres.2026.09.015_bb0270","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4306\/pi.2016.13.1.102","article-title":"Affective flattening in patients with schizophrenia: differential association with amygdala response to threat-related facial expression under automatic and controlled processing conditions","volume":"13","author":"Lindner","year":"2016","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.schres.2026.09.015_bb0275","doi-asserted-by":"crossref","first-page":"11424","DOI":"10.1523\/JNEUROSCI.2847-07.2007","article-title":"Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia","volume":"27","author":"Lodge","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.schres.2026.09.015_bb0280","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1523\/JNEUROSCI.5419-08.2009","article-title":"A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia","volume":"29","author":"Lodge","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.schres.2026.09.015_bb0285","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/wps.20385","article-title":"The current conceptualization of negative symptoms in schizophrenia","volume":"16","author":"Marder","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0290","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.tins.2018.12.004","article-title":"Schizophrenia, dopamine and the striatum: from biology to symptoms","volume":"42","author":"McCutcheon","year":"2019","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.schres.2026.09.015_bb0295","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/wps.20693","article-title":"Dopamine and glutamate in schizophrenia: biology, symptoms and treatment","volume":"19","author":"McCutcheon","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0300","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/cne.20342","article-title":"Afferent projections to nucleus reuniens of the thalamus","volume":"480","author":"McKenna","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.schres.2026.09.015_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.598811","article-title":"Acetylcholine muscarinic receptors in ventral hippocampus modulate stress-induced anxiety-like behaviors in mice","volume":"13","author":"Mei","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.schres.2026.09.015_bb0310","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyaf015","article-title":"From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1\/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials","volume":"28","author":"Meyer","year":"2025","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2026.09.015_bb0315","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tins.2014.12.005","article-title":"Translating the MAM model of psychosis to humans","volume":"38","author":"Modinos","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.schres.2026.09.015_bb0320","article-title":"Sex differences in schizophrenia: symptomatology, treatment efficacy and adverse effects","volume":"16","author":"Moniem","year":"2025","journal-title":"Front. Psychol."},{"key":"10.1016\/j.schres.2026.09.015_bb0325","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.biopsych.2006.01.003","article-title":"A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia","volume":"60","author":"Moore","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0330","article-title":"Primary and secondary negative symptoms in schizophrenia","volume":"12","author":"Mosolov","year":"2022","journal-title":"Front. Psych."},{"key":"10.1016\/j.schres.2026.09.015_bb0335","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/schbul\/sbt086","article-title":"Altered amygdala connectivity within the social brain in schizophrenia","volume":"40","author":"Mukherjee","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.09.015_bb0340","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.schres.2025.08.014","article-title":"Thalamic hyperperfusion in early schizophrenia: associations with cognitive deficits and negative symptoms","volume":"285","author":"Orlovi\u0107","year":"2025","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.09.015_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresrev.2004.04.008","article-title":"The thalamic reticular nucleus: structure, function and concept","volume":"46","author":"Pinault","year":"2004","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.schres.2026.09.015_bb0350","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1749-6632.2000.tb06738.x","article-title":"Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat: a review","volume":"911","author":"Pitk\u00e4nen","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.schres.2026.09.015_bb0355","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/mp.2009.146","article-title":"Medial prefrontal cortex pathology in schizophrenia as revealed by convergent findings from multimodal imaging","volume":"15","author":"Pomarol-Clotet","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00990","article-title":"A functional neuroimaging meta-analysis of self-related processing in schizophrenia","volume":"10","author":"Potvin","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.schres.2026.09.015_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173888","article-title":"Abnormalities in behavior relevant to schizophrenia in embryonic day 17 MAM-exposed rodent models: a systematic review and meta-analysis","volume":"245","author":"Qi","year":"2024","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.schres.2026.09.015_bb0370","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.neuroimage.2010.05.046","article-title":"Hippocampal-cortical structural connectivity disruptions in schizophrenia: an integrated perspective from hippocampal shape, cortical thickness, and integrity of white matter bundles","volume":"52","author":"Qiu","year":"2010","journal-title":"NeuroImage"},{"key":"10.1016\/j.schres.2026.09.015_bb0375","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1017\/neu.2015.11","article-title":"Negative symptoms in schizophrenia show association with amygdala volumes and neural activation during affective processing","volume":"27","author":"Rahm","year":"2015","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.schres.2026.09.015_bb0380","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0925-4927(01)00120-2","article-title":"Hippocampus and amygdala in schizophrenia: assessment of the relationship of neuroanatomy to psychopathology","volume":"108","author":"Rajarethinam","year":"2001","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2026.09.015_bb0385","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0306-4530(02)00126-9","article-title":"Effects of estrogen on brain development and neuroprotection\u2014implications for negative symptoms in schizophrenia","volume":"28","author":"Rao","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2026.09.015_bb0390","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1176\/appi.ajp.20240770","article-title":"Menopausal hormone therapy for women with schizophrenia: what\u2019s stopping us?","volume":"181","author":"Reilly","year":"2024","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2024.1347525","article-title":"Elevated fear states facilitate ventral hippocampal engagement of basolateral amygdala neuronal activity","volume":"18","author":"Ritger","year":"2024","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.schres.2026.09.015_bb0400","doi-asserted-by":"crossref","DOI":"10.1002\/hbm.26664","article-title":"Brain-based sex differences in schizophrenia: a systematic review of fMRI studies","volume":"45","author":"Salehi","year":"2024","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.schres.2026.09.015_bb0405","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pscychresns.2015.06.004","article-title":"Alterations in hippocampal connectivity across the psychosis dimension","volume":"233","author":"Samudra","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2026.09.015_bb0410","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jchemneu.2016.07.006","article-title":"The distribution of muscarinic M1 receptors in the human hippocampus","volume":"77","author":"Scarr","year":"2016","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.schres.2026.09.015_bb0415","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/archgenpsychiatry.2009.115","article-title":"Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders","volume":"66","author":"Schobel","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0420","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000440979","article-title":"Neural correlates of schizophrenia negative symptoms: distinct subtypes impact dissociable brain circuits","volume":"1","author":"Shaffer","year":"2015","journal-title":"Complex Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0425","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1358\/dof.2019.44.9.2921069","article-title":"Evenamide hydrochloride. Voltage-gated sodium channel blocker, treatment of schizophrenia","volume":"44","author":"Singh","year":"2019","journal-title":"Drugs Future"},{"key":"10.1016\/j.schres.2026.09.015_bb0430","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/schbul\/sbac139","article-title":"Women with schizophrenia-spectrum disorders after menopause: a vulnerable group for relapse","volume":"49","author":"Sommer","year":"2023","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2026.09.015_bb0435","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1038\/s41386-020-0764-2","article-title":"The mGluR2\/3 agonist pomaglumetad methionil normalizes aberrant dopamine neuron activity via action in the ventral hippocampus","volume":"45","author":"Sonnenschein","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2026.09.015_bb0440","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/mp.2017.230","article-title":"The thalamic reticular nucleus in schizophrenia and bipolar disorder: role of parvalbumin-expressing neuron networks and oxidative stress","volume":"23","author":"Steullet","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0445","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.schres.2015.12.006","article-title":"Avolition in schizophrenia is associated with reduced willingness to expend effort for reward on a progressive ratio task","volume":"170","author":"Strauss","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.09.015_bb0450","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1176\/appi.ajp.2013.13070981","article-title":"Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia","volume":"171","author":"Tregellas","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0455","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.schres.2025.09.018","article-title":"Age- and sex-dependent effects of stressors on activity of the nucleus reuniens of the thalamus","volume":"285","author":"Uliana","year":"2025","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.09.015_bb0460","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41386-020-00886-3","article-title":"Stress impacts corticoamygdalar connectivity in an age-dependent manner","volume":"46","author":"Uliana","year":"2021","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2026.09.015_bb0465","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1038\/s41386-025-02188-y","article-title":"Evenamide reverses schizophrenia-related dysfunction in a neurodevelopmental animal model","volume":"50","author":"Uliana","year":"2025","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2026.09.015_bb0470","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.schres.2026.02.010","article-title":"Novel positive allosteric modulators of alpha 5 subunit-containing GABAA receptors (\u03b15-GABAARs) reverse the hyperdopaminergic state in a neurodevelopmental model of schizophrenia","volume":"291","author":"Uliana","year":"2026","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.09.015_bb0475","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/cne.21135","article-title":"Efferent projections of reuniens and rhomboid nuclei of the thalamus in the rat","volume":"499","author":"Vertes","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.schres.2026.09.015_bb0480","series-title":"Electrophysiological Recording Techniques, Neuromethods","first-page":"55","article-title":"Nucleus Reuniens: circuitry, function, and dysfunction","author":"Vertes","year":"2022"},{"key":"10.1016\/j.schres.2026.09.015_bb0485","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00406-021-01337-w","article-title":"Limbic links to paranoia: increased resting-state functional connectivity between amygdala, hippocampus and orbitofrontal cortex in schizophrenia patients with paranoia","volume":"272","author":"Walther","year":"2022","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2026.09.015_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2012.00180","article-title":"Hippocampal temporal-parietal junction interaction in the production of psychotic symptoms: a framework for understanding the schizophrenic syndrome","volume":"6","author":"Wible","year":"2012","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.schres.2026.09.015_bb0495","doi-asserted-by":"crossref","first-page":"12871","DOI":"10.1038\/s41598-018-31163-5","article-title":"Optogenetic induction of the schizophrenia-related endophenotype of ventral hippocampal hyperactivity causes rodent correlates of positive and cognitive symptoms","volume":"8","author":"Wolff","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.schres.2026.09.015_bb0500","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41398-022-02201-8","article-title":"Neural substrates of reward anticipation and outcome in schizophrenia: a meta-analysis of fMRI findings in the monetary incentive delay task","volume":"12","author":"Zeng","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0505","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/s12888-023-05031-0","article-title":"Abnormalities of the amygdala in schizophrenia: a real world study","volume":"23","author":"Zheng","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2026.09.015_bb0510","article-title":"Sex- and exposure age-dependent effects of adolescent stress on ventral tegmental area dopamine system and its afferent regulators","author":"Zhu","year":"2022","journal-title":"Mol. Psychiatry."},{"key":"10.1016\/j.schres.2026.09.015_bb0515","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/s41380-021-01198-8","article-title":"Thalamic reticular nucleus impairments and abnormal prefrontal control of dopamine system in a developmental model of schizophrenia: prevention by N-acetylcysteine","volume":"26","author":"Zhu","year":"2021","journal-title":"Mol. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426003099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426003099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:11:18Z","timestamp":1791893478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426003099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":103,"alternative-id":["S0920996426003099"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.09.015","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hippocampal mechanisms and neural circuitry of negative symptoms in schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}